Cumulative incidence and risk factors for cutaneous squamous cell carcinoma metastases in organ transplant recipients: The Skin Care in Organ Transplant Patients in Europe-International Transplant Skin Cancer Collaborative metastases study, a prospective multicenter study.
de Jong E., Genders R., Harwood CA., Green AC., Plasmeijer EI., Proby C., Geissler E., Ferrándiz-Pulido C., Ducroux E., Euvrard S., Geusau A., Jahn-Bassler K., Borik-Heil L., Rácz E., Nägeli M., Hofbauer GFL., Piaserico S., Russo I., Mackintosh L., Borges-Costa J., Angeliki-Gkini M., Zavattaro E., Savoia P., Imko-Walszuk B., Dębska-Slizień A., Garmyn M., van Kelst S., Ricar J., Cetkovska P., Matin R., Güleç AT., Seçkin D., Anene CA., Oliveira WRP., Rademaker M., Goeman J., van Geloven N., Ruiz E., Murad F., Karn E., Schmults CD., Bouwes Bavinck JN.
INTRODUCTION: Solid organ transplant recipients (SOTRs) are believed to have an increased risk of metastatic cutaneous squamous cell carcinoma (cSCC), but reliable data are lacking regarding the precise incidence and associated risk factors. METHODS: In a prospective cohort study, including 19 specialist dermatology outpatient clinics in 15 countries, patient and tumor characteristics were collected using standardized questionnaires when SOTRs presented with a new cSCC. After a minimum of 2 years of follow-up, relevant data for all SOTRs were collected. Cumulative incidence of metastases was calculated by the Aalen-Johansen estimator. Fine and Gray models were used to assess multiple risk factors for metastases. RESULTS: Of 514 SOTRs who presented with 623 primary cSCCs, metastases developed in 37 with a 2-year patient-based cumulative incidence of 6.2%. Risk factors for metastases included location in the head and neck area, local recurrence, size > 2 cm, clinical ulceration, poor differentiation grade, perineural invasion, and deep invasion. A high-stage tumor that is also ulcerated showed the highest risk of metastasis, with a 2-year cumulative incidence of 46.2% (31.9%-68.4%). CONCLUSIONS: SOTRs have a high risk of cSCC metastases and well-established clinical and histologic risk factors have been confirmed. High-stage, ulcerated cSCCs have the highest risk of metastasis.